As mentioned previously, high levels of PLK4 expression induce anoikis resistance of both p53KO mammary epithelial and breast cancer cells exposed to their secretome, and likely modulate the tumor microenvironment to promote breast cancer tumorigenesis [101]. The gene discussed is PLK4; the disease is breast carcinoma.